These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29923974)

  • 21. Prognostic significance of inflammatory indices in hepatocellular carcinoma treated with transarterial chemoembolization: A systematic review and meta-analysis.
    Li S; Feng X; Cao G; Wang Q; Wang L
    PLoS One; 2020; 15(3):e0230879. PubMed ID: 32214401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FIB-4 index serves as a noninvasive prognostic biomarker in patients with hepatocellular carcinoma: A meta-analysis.
    Zhang Y; Wang R; Yang X
    Medicine (Baltimore); 2018 Dec; 97(51):e13696. PubMed ID: 30572498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological and prognostic significance of platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma.
    Song W; Wang K; Zhong FP; Fan YW; Peng L; Zou SB
    Oncotarget; 2016 Dec; 7(49):81830-81838. PubMed ID: 27833084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Prognostic Value of Pretreatment Plasma Fibrinogen in Urological Cancers: A Systematic Review and Meta-analysis.
    Song H; Kuang G; Zhang Z; Ma B; Jin J; Zhang Q
    J Cancer; 2019; 10(2):479-487. PubMed ID: 30719143
    [No Abstract]   [Full Text] [Related]  

  • 25. Association between D-dimer levels and clinicopathological characteristics of pancreatic cancer and its role in prognosis: A systematic review and meta-analysis.
    Wu B; Zhang G; Zhao X; Wang J; Wang D; Zhang Y; Yu M; Cai H
    Asian J Surg; 2024 Aug; 47(8):3417-3424. PubMed ID: 38453610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The EpCAM overexpression is associated with clinicopathological significance and prognosis in hepatocellular carcinoma patients: A systematic review and meta-analysis.
    Zhou L; Zhu Y
    Int J Surg; 2018 Aug; 56():274-280. PubMed ID: 29936198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of combined preoperative fibrinogen and neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation.
    Fu SJ; Ji F; Han M; Chen MG; Wang XP; Ju WQ; Zhao Q; Wu LW; Ren QQ; Guo ZY; Wang DP; Zhu XF; Ma Y; He XS
    Oncotarget; 2017 Jan; 8(3):4301-4312. PubMed ID: 27935864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pretransplant neutrophil-lymphocyte ratio as a new prognostic predictor after liver transplantation for hepatocellular cancer: a systematic review and meta-analysis.
    Xu ZG; Ye CJ; Liu LX; Wu G; Zhao ZX; Wang YZ; Shi BQ; Wang YH
    Biomark Med; 2018 Feb; 12(2):189-199. PubMed ID: 29327595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of parameters from pretreatment (18)F-FDG PET in hepatocellular carcinoma: a meta-analysis.
    Sun DW; An L; Wei F; Mu L; Shi XJ; Wang CL; Zhao ZW; Li TF; Lv GY
    Abdom Radiol (NY); 2016 Jan; 41(1):33-41. PubMed ID: 26830609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysis.
    Wang Y; Peng C; Cheng Z; Wang X; Wu L; Li J; Huang C; Guo Q; Cai H
    Int J Surg; 2018 Jul; 55():73-80. PubMed ID: 29787804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis.
    Zhao Y; Si G; Zhu F; Hui J; Cai S; Huang C; Cheng S; Fathy AH; Xiang Y; Li J
    Oncotarget; 2017 Apr; 8(14):22854-22862. PubMed ID: 28206965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma.
    Wu MT; He SY; Chen SL; Li LF; He ZQ; Zhu YY; He X; Chen H
    BMC Cancer; 2019 Jun; 19(1):538. PubMed ID: 31164099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between platelet to lymphocyte ratio (PLR) and overall survival (OS) of hepatocellular carcinoma (HCC): A meta-analysis.
    Hu DH; Yu SM
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):30-32. PubMed ID: 28886327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological and prognostic value of preoperative plasma fibrinogen in gastric cancer patients: A meta-analysis.
    Cheng F; Zeng C; Zeng L; Chen Y
    Medicine (Baltimore); 2019 Oct; 98(40):e17310. PubMed ID: 31577724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperfibrinogen Is Associated With the Systemic Inflammatory Response and Predicts Poor Prognosis in Advanced Pancreatic Cancer.
    Qi Q; Geng Y; Sun M; Chen H; Wang P; Chen Z
    Pancreas; 2015 Aug; 44(6):977-82. PubMed ID: 25931258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies.
    Bruix J; Cheng AL; Meinhardt G; Nakajima K; De Sanctis Y; Llovet J
    J Hepatol; 2017 Nov; 67(5):999-1008. PubMed ID: 28687477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
    Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
    Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic significance of pretreatment serum γ-glutamyltranspeptidase in primary liver cancer: a meta-analysis and systematic review.
    Ou Y; Huang J; Yang L
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30389711
    [No Abstract]   [Full Text] [Related]  

  • 39. Adipose distribution patterns as prognostic factors in patients with HCC: A systematic review and meta-analysis.
    Shi S; Yi H; Zheng Y; Zhao Y; Yu D
    Eur J Radiol; 2023 Oct; 167():111025. PubMed ID: 37634440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma.
    Zhao YM; Wang L; Dai Z; Wang DD; Hei ZY; Zhang N; Fu XT; Wang XL; Zhang SC; Qin LX; Tang ZY; Zhou J; Fan J
    Int J Cancer; 2011 Nov; 129(10):2463-72. PubMed ID: 21213214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.